These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Field dependency, n power and locus of control variables in alcohol aversion. Query WT J Clin Psychol; 1983 Mar; 39(2):279-83. PubMed ID: 6841633 [TBL] [Abstract][Full Text] [Related]
25. A comparison of cessation strategies for the outpatient alcoholic. Telch MJ; Hannon R; Telch CF Addict Behav; 1984; 9(1):103-9. PubMed ID: 6741666 [TBL] [Abstract][Full Text] [Related]
26. Emetic and electric shock alcohol aversion therapy: assessment of conditioning. Cannon DS; Baker TB J Consult Clin Psychol; 1981 Feb; 49(1):20-33. PubMed ID: 7217473 [No Abstract] [Full Text] [Related]
27. Clinical issues related to the costs of alcoholism. Howard MO; McGuffin RW; Saxon AJ; Sloan KL; Walker RD Pharmacoeconomics; 1996 Feb; 9(2):134-45. PubMed ID: 10160092 [TBL] [Abstract][Full Text] [Related]
28. Long-term abstinence from alcohol in patients receiving aversion therapy as part of a multimodal inpatient program. Smith JW; Frawley PJ J Subst Abuse Treat; 1990; 7(2):77-82. PubMed ID: 2167389 [TBL] [Abstract][Full Text] [Related]
29. Aversion conditioning treatment of alcoholism. Holzinger R; Mortimer R; Van Dusen W Am J Psychiatry; 1967 Aug; 124(2):246-7. PubMed ID: 4951586 [No Abstract] [Full Text] [Related]
30. gamma-Hydroxybutyric acid in the treatment of alcohol dependence: possible craving development for the drug. Addolorato G; Caputo F; Stefanini GF; Gasbarrini G Addiction; 1997 Aug; 92(8):1035-6. PubMed ID: 9376774 [No Abstract] [Full Text] [Related]
31. Drug-induced attenuation of alcohol consumption. A review and evaluation of claimed, potential or current therapies. Mottin JL Q J Stud Alcohol; 1973 Jun; 34(2):444-72. PubMed ID: 4270100 [No Abstract] [Full Text] [Related]
32. [New drugs in the treatment of alcoholism]. Besson J Schweiz Med Wochenschr; 1997 Sep; 127(38):1574-8. PubMed ID: 9411716 [TBL] [Abstract][Full Text] [Related]
33. Effect of community nurse follow-up when treating alcohol dependence with acamprosate. Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092 [TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy and psychotherapy for the treatment of alcoholism in Germany. Soyka M Drug Alcohol Depend; 1995 Sep; 39 Suppl 1():S9-13. PubMed ID: 8565796 [TBL] [Abstract][Full Text] [Related]
35. [Advances in the field of alcohol-aversive agents]. Weigand K Ther Umsch; 1982 Nov; 39(11):891-6. PubMed ID: 6758176 [No Abstract] [Full Text] [Related]
36. Rat data which suggest alcoholic beverages should be swallowed during chemical aversion therapy, not just tasted. Revusky S; Parker LA; Coombes J; Coombes S Behav Res Ther; 1976; 14(3):189-94. PubMed ID: 986815 [No Abstract] [Full Text] [Related]
37. Reducing the desire to drink. Pharmacology and neurobiology. Litten RZ; Allen JP Recent Dev Alcohol; 1993; 11():325-44. PubMed ID: 8234930 [TBL] [Abstract][Full Text] [Related]
38. [Mechanism of action of disulfiram and treatment optimization in prevention of recurrent alcoholism]. Mutschler J; Kiefer F Praxis (Bern 1994); 2013 Jan; 102(3):139-46. PubMed ID: 23384983 [TBL] [Abstract][Full Text] [Related]
39. Advances in the use of naltrexone: an integration of preclinical and clinical findings. O'Malley SS; Froehlich JC Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640 [TBL] [Abstract][Full Text] [Related]
40. [Disulfiram in outpatient treatment of alcohol dependency]. Hochsattel K; Brieger P Nervenarzt; 2016 May; 87(5):506-12. PubMed ID: 26122638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]